Posted by Michael Wonder on 03 Sep 2022
Pfizer/BioNTech bivalent COVID-19 booster approved by UK medicines regulator
3 September 2022 - The adapted COVID-19 vaccine targets both the original virus and the Omicron variant.
A second, “bivalent” vaccine has today been approved as a booster by the MHRA after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.
